Executive Medical Director for Urology, Astellas
Pamela Bradt has served in senior scientific leadership positions in industry, academia, and clinical practice. She has special expertise in evidence strategy planning, health economics and clinical outcomes, pharmacoepidemiology, and evidence-based decision making for products and devices. Dr. Bradt has a 25-year broad based research experience using a variety of study designs, has served as faculty at a number of national and international workshops on evidence-based medicine, and was the first industry physician invited to speak at the World Health Organization on public health research strategies for high risk obstetric and pediatric patients. Prior to joining industry she provided intensive care to premature and high-risk infants, served as medical director for a large high-risk follow-up program and was faculty at the Center for Evidence Based Medicine at the University of Texas in Houston.